Comparison between Magnesium Sulphate & Buprenorphine as an additive to Bupivacaine in Ultrasound guided Transverse Abdominis Plane block as post-operative analgesia for pregnant patients undergoing caesarean section surgery.
Not Applicable
- Conditions
- Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
- Registration Number
- CTRI/2023/06/054061
- Lead Sponsor
- DR ASHOK KULASEKAR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Elective and emergency caesarean section
ASA - II and III
Exclusion Criteria
Age : < 18 years and > 40 years of age
Patient refusal
Allergic to Local anaesthetic
Bleeding disorder
Parturients who is already on MgSO4 for Pre-eclampsia / Eclampsia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study will be used to compare the duration of post operative analgesia between Magnesium Sulphate & Buprenorphine <br/ ><br>added to Bupivacaine in Transverse Abdominis Plane block in Caesarean section patients.Timepoint: 24hours
- Secondary Outcome Measures
Name Time Method To assess the total requirement of rescue analgesia over a period of 24 hours post-operatively <br/ ><br> <br/ ><br>Timepoint: 24hours;To assess the Intensity of post-operative pain , Haemodynamic status of parturients over 24 hours post-operativelyTimepoint: 24hours;To assess the time taken for the requirement of first dose of rescue analgesic <br/ ><br>Timepoint: 24hours